Rakesh K. Jain
- Harvard Medical School
Our research goals are (i) to understand how the abnormal tumor microenvironment confers resistance to various cancer treatments (e.g., molecular therapeutics, nanotherapeutics, radiation and immunotherapy), (ii) to develop and test new strategies to overcome this resistance, and (iii) to translate these strategies from bench to bedside through multi-disciplinary clinical trials. This tight integration between bench and bedside and application of engineering/physical science principles to oncology is a hallmark of our research.
|Sep. 11 (Fri)
||Room 1 & 2 & 3
||Plenary Lecture 08
Normalizing the Tumor Microenvironment to Improve Cancer Immunotherapy: Bench to Bedside
||Normalizing the Tumor Microenvironment to Improve Cancer Immunotherapy: Bench to Bedside